[16] [17] Many patients with type 2 diabetes or obesity also have cardiovascular comorbidities requiring anticoagulation therapy
Both medications carry rare but serious risks like pancreatitis, thyroid concerns, or kidney problems
Some keywords that were very popular one month may suddenly become very negative
Additionally, Etidronate, Melatonin, and Albendazole were excluded due to poor bioavailability 82,83,84 , and Eplerenone was excluded due to solubility concerns 85
Research is still in the early stages, but GLP-1 medications could one day become an important part of PMOS care
5.2 Ovarian Hyperstimulation Syndrome (OHSS) Ovarian Hyperstimulation Syndrome (OHSS) is a medical entity distinct from uncomplicated ovarian enlargement and may progress rapidly to become a serious medical event